Target intelligence / Profile preview

Goldenrod extract (Solidago virgaurea)

Molecular classification
Herbal extract, Natural product mixture, Phytotherapeutic agent
01

Overview

Goldenrod extract is a complex botanical preparation derived from the aerial parts of plants in the Solidago genus, most commonly Solidago virgaurea. It is not a discrete molecular target but rather a multi-component therapeutic mixture containing bioactive secondary metabolites such as flavonoids, triterpene saponins, and phenolic acids (Melzig, 2004). Historically used in traditional medicine, it is primarily recognized for its aquaretic, anti-inflammatory, and antispasmodic properties. In modern phytotherapy, it is frequently employed as an adjuvant treatment for inflammatory diseases of the lower urinary tract and for the prevention of renal calculi (Thiem & Goślińska, 2004). The extract's efficacy is attributed to its ability to increase urine flow without significant electrolyte loss and to inhibit the synthesis of inflammatory prostaglandins and leukotrienes. While generally considered safe, it should be avoided by individuals with known allergies to the Asteraceae family or those with fluid-restrictive conditions like congestive heart failure. As a complex mixture, it does not target a single receptor but modulates various physiological pathways involved in renal excretion and inflammation.

Other names
Solidago virgaurea extractEuropean GoldenrodWoundwortSolidaginis virgaureae herbaAaron's rod
02

Mechanism of action

The extract exerts its therapeutic effects through the synergistic action of its constituents: flavonoids (e.g., quercetin, rutin) and saponins inhibit inflammatory mediators such as 5-lipoxygenase and cyclooxygenase; phenolic acids provide antioxidant protection; and the complex mixture promotes aquaresis (water diuresis) and smooth muscle relaxation in the urinary tract (Melzig, 2004; EMA, 2008).

03

Biological functions

DiureticAnti-inflammatoryAntispasmodicAntioxidantAntimicrobial
04

Disease associations

Urinary tract infectionUrolithiasisCystitisInflammationOveractive bladder
05

Safety considerations

Hypersensitivity to plants in the Asteraceae (Compositae) familyPotential for dehydration if fluid intake is insufficientContraindicated for irrigation therapy in patients with edema due to cardiac or renal insufficiency (EMA, 2008)
06

Interacting drugs

Diuretics

2 more in the full profile.

07

Biomarkers

Urine volumeUrinary pHC-reactive protein (CRP)Urinary leukocyte count

Beyond the preview

Go deeper on Goldenrod extract (Solidago virgaurea).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goldenrod extract (Solidago virgaurea).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call